Research Article
Evaluation of Quality of Life and Satisfaction of Patients with Neuropathic Pain and Breakthrough Pain: Economic Impact Based on Quality of Life
Table 2
Active ingredients administered to treat BTP.
| | | N | % |
| | Acetylsalicylic acid | 1 | 0.8 | | Bromazepam | 1 | 0.8 | | Clonazepam | 1 | 0.8 | | Dexketoprofen | 2 | 1.6 | | Fentanyl | 86 | 70.5 | | Gabapentin | 1 | 0.8 | | Ibuprofen | 1 | 0.8 | | Lidocaine | 2 | 1.6 | | Metamizole | 6 | 4.9 | | Morphine | 4 | 3.3 | | Naproxen | 1 | 0.8 | | Oxycodone | 2 | 1.6 | | Acetaminophen/Caffeine/ Codeine | 1 | 0.8 | | Pregabalin | 1 | 0.8 | | Tramadol | 8 | 6.6 | | Tramadol/Acetaminophen | 4 | 3.3 |
| | Total | 122 | |
|
|
